Education
About Us
Working with TipRanks
Follow Us
Heart Test Laboratories, Inc. (HSCS)
NASDAQ:HSCS
RESEARCH TOOLSreports
Total Valuation
Heart Test Laboratories, Inc. has a market cap or net worth of $3.61M. The enterprise value is ―.
Market Cap$3.61M
Enterprise Value―
Share Statistics
Heart Test Laboratories, Inc. has 1,080,946 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,080,946
Owned by Insiders0.71%
Owned by Institutions0.03%
Financial Efficiency
Heart Test Laboratories, Inc.’s return on equity (ROE) is -0.90 and return on invested capital (ROIC) is -75.49%.
Return on Equity (ROE)-0.90
Return on Assets (ROA)-0.70
Return on Invested Capital (ROIC)-75.49%
Return on Capital Employed (ROCE)-0.81
Revenue Per Employee1.24K
Profits Per Employee-440.35K
Employee Count15
Asset Turnover<0.01
Inventory Turnover<0.01
Valuation Ratios
The current PE Ratio of Heart Test Laboratories, Inc. is -0.49. Heart Test Laboratories, Inc.’s PEG ratio is <0.01.
PE Ratio-0.49
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value0.45
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio<0.01
Income Statement
In the last 12 months, Heart Test Laboratories, Inc. had revenue of 18.60K and earned -6.61M in profits. Earnings per share was -18.74.
Revenue18.60K
Gross Profit12.52K
Operating Income-6.31M
Pretax Income-6.61M
Net Income-6.61M
EBITDA-6.16M
Earnings Per Share (EPS)-18.74
Cash Flow
In the last 12 months, operating cash flow was -4.21B and capital expenditures -131.99K, giving a free cash flow of -4.21B billion.
Operating Cash Flow-4.21B
Free Cash Flow-4.21B
Free Cash Flow per Share-3.89K
Dividends & Yields
Heart Test Laboratories, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.60
52-Week Price Change-52.65%
50-Day Moving Average3.15
200-Day Moving Average3.37
Relative Strength Index (RSI)48.61
Average Volume (3m)13.09K
Important Dates
Heart Test Laboratories, Inc. upcoming earnings date is Sep 11, 2025, TBA Not Confirmed.
Last Earnings DateMar 13, 2025
Next Earnings DateSep 11, 2025
Ex-Dividend Date―
Financial Position
Heart Test Laboratories, Inc. as a current ratio of 4.20, with Debt / Equity ratio of 0.17%
Current Ratio4.20
Quick Ratio3.84
Debt to Market Cap0.15
Net Debt to EBITDA0.78
Interest Coverage Ratio-17.81
Taxes
In the past 12 months, Heart Test Laboratories, Inc. has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Heart Test Laboratories, Inc. EV to EBITDA ratio is 0.25, with an EV/FCF ratio of 0.24.
EV to Sales-81.40
EV to EBITDA0.25
EV to Free Cash Flow0.24
EV to Operating Cash Flow0.25
Balance Sheet
Heart Test Laboratories, Inc. has $2.60M in cash and marketable securities with $2.99M in debt, giving a net cash position of $390.56K billion.
Cash & Marketable Securities$2.60M
Total Debt$2.99M
Net Cash$390.56K
Net Cash Per Share$0.36
Tangible Book Value Per Share$16.25
Margins
Gross margin is 0.00%, with operating margin of -33901.99%, and net profit margin of -35511.87%.
Gross Margin0.00%
Operating Margin-33901.99%
Pretax Margin-35511.87%
Net Profit Margin-35511.87%
EBITDA Margin-33096.75%
EBIT Margin-33608.22%
Analyst Forecast
The average price target for Heart Test Laboratories, Inc. is $13.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$13.00
Price Target Upside289.22% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-100.00%
EPS Growth Forecast78.91%